Retagliptin Phosphate
Retagliptin Phosphate (SP 2086) is a small molecule DPP-4 inhibitor used in research for type 2 diabetes. It is applied in both in vitro enzymatic assays and in vivo animal studies to investigate mechanisms of glycemic control and incretin hormone potentiation.
Product Specifications
CAS Number
1256756-88-3
Product Name Alternative
GLP-1, Inhibitor, inhibit, DPP, DPP-4, DPP4, Dipeptidyl Peptidase, Retagliptin, Retagliptin Phosphate, T2DM, SP2086, SP-2086, SP 2086
Field of Research
Protein Biochemistry
Purity
98.70% (May vary between batches)
Solubility
DMSO:≥ 150 mg/mL (266.73 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (3.56 mM)
Smiles
P (=O) (O) (O) O.C (OC) (=O) C1=C2N (C (C (F) (F) F) =N1) CCN (C (C[C@@H] (CC3=C (F) C=C (F) C (F) =C3) N) =O) C2
Molecular Formula
C19H21F6N4O7P
Molecular Weight
562.36
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
